These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 32184782)

  • 1. Myeloid Cell-Mediated Trained Innate Immunity in Mucosal AIDS Vaccine Development.
    Sui Y; Berzofsky JA
    Front Immunol; 2020; 11():315. PubMed ID: 32184782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The causes and consequences of trained immunity in myeloid cells.
    Bhargavi G; Subbian S
    Front Immunol; 2024; 15():1365127. PubMed ID: 38665915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular and Cellular Mechanisms Modulating Trained Immunity by Various Cell Types in Response to Pathogen Encounter.
    Acevedo OA; Berrios RV; Rodríguez-Guilarte L; Lillo-Dapremont B; Kalergis AM
    Front Immunol; 2021; 12():745332. PubMed ID: 34671359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucosal immunity and HIV-1 infection: applications for mucosal AIDS vaccine development.
    Belyakov IM; Ahlers JD
    Curr Top Microbiol Immunol; 2012; 354():157-79. PubMed ID: 21203884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Translational Mini-Review Series on Vaccines for HIV: Harnessing innate immunity for HIV vaccine development.
    Rhee EG; Barouch DH
    Clin Exp Immunol; 2009 Aug; 157(2):174-80. PubMed ID: 19604256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trained Immunity and Cardiometabolic Disease: The Role of Bone Marrow.
    Mitroulis I; Hajishengallis G; Chavakis T
    Arterioscler Thromb Vasc Biol; 2021 Jan; 41(1):48-54. PubMed ID: 33207931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Innate Immune Memory in Hematopoietic Stem/Progenitor Cells: Myeloid-Biased Differentiation and the Role of Interferon.
    Chen L; Ozato K
    Front Immunol; 2021; 12():621333. PubMed ID: 33854500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innate immune memory of tissue-resident macrophages and trained innate immunity: Re-vamping vaccine concept and strategies.
    Xing Z; Afkhami S; Bavananthasivam J; Fritz DK; D'Agostino MR; Vaseghi-Shanjani M; Yao Y; Jeyanathan M
    J Leukoc Biol; 2020 Sep; 108(3):825-834. PubMed ID: 32125045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucosal AIDS vaccines: current status and future directions.
    Belyakov IM; Ahlers JD; Berzofsky JA
    Expert Rev Vaccines; 2004 Aug; 3(4 Suppl):S65-73. PubMed ID: 15285706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trained Immunity-Based Vaccines: A New Paradigm for the Development of Broad-Spectrum Anti-infectious Formulations.
    Sánchez-Ramón S; Conejero L; Netea MG; Sancho D; Palomares Ó; Subiza JL
    Front Immunol; 2018; 9():2936. PubMed ID: 30619296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trained innate immunity as underlying mechanism for the long-term, nonspecific effects of vaccines.
    Blok BA; Arts RJ; van Crevel R; Benn CS; Netea MG
    J Leukoc Biol; 2015 Sep; 98(3):347-56. PubMed ID: 26150551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucosal Vaccination for Prevention of HIV Infection and AIDS.
    Aldovini A
    Curr HIV Res; 2016; 14(3):247-59. PubMed ID: 26957199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effects of Trained Innate Immunity on T Cell Responses; Clinical Implications and Knowledge Gaps for Future Research.
    Murphy DM; Mills KHG; Basdeo SA
    Front Immunol; 2021; 12():706583. PubMed ID: 34489958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances and challenges in recombinant Mycobacterium bovis BCG-based HIV vaccine development: lessons learned.
    Kilpeläinen A; Maya-Hoyos M; Saubí N; Soto CY; Joseph Munne J
    Expert Rev Vaccines; 2018 Nov; 17(11):1005-1020. PubMed ID: 30300040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Introduction: Back to basics: mucosal immunity and novel HIV vaccine concepts.
    Broliden K; Haase AT; Ahuja SK; Shearer GM; Andersson J
    J Intern Med; 2009 Jan; 265(1):5-17. PubMed ID: 19093956
    [No Abstract]   [Full Text] [Related]  

  • 16. Western Diet Triggers NLRP3-Dependent Innate Immune Reprogramming.
    Christ A; Günther P; Lauterbach MAR; Duewell P; Biswas D; Pelka K; Scholz CJ; Oosting M; Haendler K; Baßler K; Klee K; Schulte-Schrepping J; Ulas T; Moorlag SJCFM; Kumar V; Park MH; Joosten LAB; Groh LA; Riksen NP; Espevik T; Schlitzer A; Li Y; Fitzgerald ML; Netea MG; Schultze JL; Latz E
    Cell; 2018 Jan; 172(1-2):162-175.e14. PubMed ID: 29328911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional CD8+ CTLs in mucosal sites and HIV infection: moving forward toward a mucosal AIDS vaccine.
    Belyakov IM; Ahlers JD
    Trends Immunol; 2008 Nov; 29(11):574-85. PubMed ID: 18838298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel HIV IL-4R antagonist vaccine strategy can induce both high avidity CD8 T and B cell immunity with greater protective efficacy.
    Jackson RJ; Worley M; Trivedi S; Ranasinghe C
    Vaccine; 2014 Sep; 32(43):5703-14. PubMed ID: 25151041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trained immunity-related vaccines: innate immune memory and heterologous protection against infections.
    Ziogas A; Netea MG
    Trends Mol Med; 2022 Jun; 28(6):497-512. PubMed ID: 35466062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membrane-anchored CCL20 augments HIV Env-specific mucosal immune responses.
    Sun X; Zhang H; Xu S; Shi L; Dong J; Gao D; Chen Y; Feng H
    Virol J; 2017 Aug; 14(1):163. PubMed ID: 28830557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.